Boris Peaker is Executive Director and Senior Analyst at Oppenheimer & Co. Inc., covering the biotechnology sector. Prior to joining Oppenheimer & Co., Inc., Mr. Peaker worked at Rodman & Renshaw covering small and midcap biotech companies across multiple therapeutic areas. Prior to Rodman & Renshaw, Mr. Peaker covered mid- and large-cap U.S.-based biopharmaceutical and biotechnology companies at Cowen Group, Inc. Mr. Peaker began his career as a Consultant at Keelin Reeds Partners in California, working exclusively with biotech and pharmaceutical companies on asset valuation, R&D portfolio management, M&A strategy, and royalty and equity financing. Mr. Peaker holds a Ph.D. in biophysics from Stanford University and a dual B.S. in physics and chemistry from SUNY at Stony Brook.